Research Article

Immunologic Response of HIV-Infected Children to Different Regimens of Antiretroviral Therapy: A Retrospective Observational Study

Table 3

Random-effect linear regression analysis of trend of CD4+ count (slope, cells/mm3/6 month) at JMC, from April 10 to May 10, 2017.

Variablesn (%)Unadjusted %β [95%CI] valueAdjusted %β [95%CI] value

SexMale98 (54.75)0
Female81 (45.25)7.46[−13.61−28.53]0.488

Age: median (IQR)7 (4–9)179 (100)−0.56[−4.24−3.12]0.765

BMIBelow 5th centile140 (78.21)−19.45[−44.56−5.70]0.130−5.18[−22.99−12.63]0.569
Above 5th centile39 (21.79)00

Weight for height≤70%36 (20.11)−31.84[−57.96− (−5.72)]0.0172.31[−18.10−22.72]0.825
70–85%14 (7.82)−9.84[−48.62−28.94]0.6195.91[−21.17−32.99]0.669
≥85%129 (72.07)00

In care of the childMother24 (13.41)16.91[−13.74−47.57]0.280
Others155 (86.59)0

Maternal statusDead33 (18.44)−3.244[−30.53−24.06]0.816
Live146 (8156)0

Maternal serostatusUnknown18 (10.06)−5.01[−40.54−30.53]0.782
Negative161 (89.94)0

Paternal statusDead47 (26.26)0.32[−23.39−24.03]0.979
Live132 (73.74)0

ResidenceUrban134 (78.86)0
Rural45 (25.14)−6.59[−31.04−17.87]0.598

ART groupABC87 (48.60)00
AZT92 (51.40)30.42[9.89–50.94]0.00420.51[6.37−34.65]0.004

CD4 count162 (117–221)179 (100)0.72[0.62–0.82]≤0.0010.55[0.49−0.69]≤0.001
OI occurredNo12100
Yes58−49.12[−70.49− (−27.74)]≤0.001−18.65[−5.49−42.78]0.130

Viral load≤1000 copies/ml146 (83.43)0
>1000 copies/ml29 (16.57)−50.21[−77.71− (−22.71)]≤0.001−27.68[−47.75− (−7.61)]0.007

WHO stageStage I11 (6.15)00
Stage II64 (35.75)−31.43[−73.23−10.37]0.141−28.63[−64.05−6.71]0.112
Stage III87 (48.60)−94.64[−136.08− (−53.19)]≤0.001−47.61[−84.27− (−10.96)]0.011
Stage IV17 (9.50)−151.41[−199.26− (−103.56)]≤0.001−73.54[−118.27− (−28.81)]0.001

Nutritional statusNormal102 (57.00)00
SAM77 (43.00)−38.79[−59.28− (−18.30)]≤0.001−13.42[−35.34−8.50]0.230

TB treatmentNo166 (92.74)00
Yes13 (7.26)−61.14[−103.84− (−18.43)]0.005−32.58[−65.18−0.21]0.050